A Spanish company specializing in the pharmaceutical industry said, Friday, that a drug to treat cancer has shown promising results in the treatment of "Covid 19" disease, which results from infection with the emerging corona virus.
According to "Reuters", the "Pharma Mar" company said that a clinical trial of the drug revealed the drug’s efficacy among adults, expressing its hope for the start of the third phase of clinical trials.
The shares of the "Pharma Mar" company rose by more than 10 percent in trading on Friday morning, and its value increased by more than three times, thanks to the promising results of the drug "Aplidin".
The company stated that the drug led to a decrease in the amount of "virus protein" in the patients' body, so 80.7 percent of its users were discharged from the hospital before the fifteenth day of treatment, while 38.2 percent left before the eighth day.
The company stated, in a statement, that in light of these results, it decided to enter into discussions with the agencies that oversee health affairs in order to arrange the third phase of clinical trials.